NCT07150520Not yet recruiting
VR-Based Optokinetic Stimulation in Multiple Sclerosis
Acute Effects of Virtual Reality-Based Optokinetic Stimulation in Individuals With Multiple Sclerosis: Does Central Vestibular Dysfunction Alter These Effects?
Source: ClinicalTrials.gov · Last updated 9 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to investigate the acute effects of virtual reality-based optokinetic stimulation on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS)
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 25 Aug 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Avrasya University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07150520
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 15 Sept 2025 to the primary completion date, 31 Oct 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have any cardiovascular, orthopedic, neurological, or other condition preventing assessments
- Have a history of neurological disorders, head trauma, or chronic psychiatric conditions (for healthy controls)
Age
- Be older than 55 years
Other
- Have peripheral vestibular dysfunction (for MS groups)
Who the study is looking for
- Be an adult aged 18-55 years
- Have a confirmed diagnosis of MS by a neurologist (for MS groups)
- Not have had a relapse in the last 3 months (for MS patients)
- Have an Expanded Disability Status Scale (EDSS) score of ≤ 4 (for MS patients)
- Be a healthy control with no condition preventing participation
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.